018456490

Tamsunorm Combi

---

April 19, 2021

Trademark Summary

The trademark application Tamsunorm Combi was filed by Bausch Health Ireland Limited, a corporation established under the laws of Ireland (the "Applicant"). The application was published for oppositions on May 11, 2021, and it was registered by office on August 18, 2021 without any oppositions.

It was designated 'Basic Application' for International Application 1599912 at the World Intellectual Property Organization (WIPO).

The application was filed in English (German was selected as the second language).

Change of name and address of the trademark registration was recorded on May 25, 2022.

---

Goods And Services

• The mark was filed in class 5 with Pharmaceutical products, medicines for the treatment of benign prostatic hypertrophies.